VR and Script Training of PWA

March 11, 2025 updated by: The Hong Kong Polytechnic University

Utilization of Immersive Virtual Reality in Computerized Script Training for People with Aphasia: a Feasibility Study

The goal of this intervention study is to investigate the effects of immersive virtual reality in rehabilitation of language and communication of individuals with post-stroke aphasia. The main research questions are:

  1. Is VR-based script training a feasible treatment to Cantonese-speaking PWA?
  2. Will VR-based script training, when compared to conventional script training, better enhance treatment outcomes in functional communication of PWA?

Participants will be assessed before, in the middle of, immediately after treatment and 8-week post treatment in terms of their performance on:

  1. Accuracy and time for producing trained scripts.
  2. Accuracy and time for producing un-trained scripts
  3. Standardized aphasia test on severity of language impairment
  4. Standardized aphasia test on functional communication

The participants will be randomly allocated to receive one of the treatment:

  1. Virtual reality-based computerized script training; or
  2. Computerized script training without virtual reality Researchers will compare the treatment outcomes of the two treatment conditions and see if treatment with virtual reality would better promote outcomes when compared to training without virtual reality.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hong Kong SAR
      • Hong Kong, Hong Kong SAR, Hong Kong, 852
        • Hong Kong Polytechnic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. a stroke onset more than six months, with an Aphasia Quotient (AQ) below 96.4, as evaluated by the Cantonese version of Western Aphasia Battery (CAB; Yiu, 1992),
  2. premorbid fluent Cantonese speakers,
  3. aged between 30 and 80 years,
  4. no reported progressive neurogenic disorders such as dementia or Parkinson's disease,
  5. no motor speech disorders of moderate to severe level, and
  6. normal or corrected-to-normal vision and hearing functions

Exclusion Criteria:

  1. concurrent participation in other aphasia treatment trials, and
  2. incompatibility with immersive VR exposure such as complains of nausea, headache, or other severe discomforts during trial use of a head-mounted device during screening.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VR-based script training
The PWA will wear a head-mounted VR device (e.g., Metaverse Oculus Quest 2 or other commercially available devices) for 30 minutes, which intends to create an immersive environment for training. Scripts trained in the computerized script training program in a particular session will be practiced. Cinematic 360˚ photo-real scenarios of daily contexts such as a restaurant or a grocery store will be displayed in the device while a communication partner, e.g., a waiter in the restaurant or a shopkeeper of a grocery store will initiate the conversation by producing the corresponding part of the script. The PWA will be given time to respond. Upon the completion of PWA's respond, the next conversational turn will be initiated. The clinical assistant, who accompanies the PWA in the entire training session, will control the flow of the 360 ˚ videos.
Active Comparator: Conventional script training
The flow of training is identical to the VR condition, except that photos depicting the scenarios and pre-recorded conversational turns will be presented to the PWA on a computer screen with the same procedures mentioned in the VR condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage correct in reading aloud the sentences included in the trained scripts
Time Frame: From baseline up to 1-week post training
Trained scripts will be shown in written form while the PWA will be asked to read aloud the scripts.
From baseline up to 1-week post training
Time required in read aloud of trained scripts
Time Frame: From baseline up to 1-week post training
Total time to read aloud the trained scripts
From baseline up to 1-week post training
Percentage correct in spontaneous production of the sentences included in the trained scripts
Time Frame: From baseline up to 1-week post training
No written cue will be provided while the PWA will produce the scripts upon questions.
From baseline up to 1-week post training
Time required for spantaneous production of trained scripts
Time Frame: From baseline up to 1-week post training
No written cue will be provided while the PWA will produce the scripts upon questions.
From baseline up to 1-week post training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CAB
Time Frame: From baseline up to 1-week post training
Cantonese version of the Western Aphasia Battery
From baseline up to 1-week post training
CANELT
Time Frame: From baseline up to 1-week post training
Cantonese version of the Amsterdam-Nijmegen Everyday Language Test (ANELT; Blomert et al., 1994)
From baseline up to 1-week post training
Percentage correct in producing untrained but related scripts
Time Frame: From baseline up to 1-week post training
No written cue will be provided while the PWA will produce the untrained scripts that share similar contexts with the trained scripts.
From baseline up to 1-week post training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Winsy WS Wong, PhD, Hong Kong Polytechnic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2023

Primary Completion (Actual)

December 31, 2024

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

December 11, 2022

First Submitted That Met QC Criteria

December 19, 2022

First Posted (Actual)

December 28, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 11, 2025

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The IPD, together with the study protocol, will be shared in an open-access data repository (e.g., Harvard Dataverse).

IPD Sharing Time Frame

Data will be shared starting from three months after manuscript publication.

IPD Sharing Access Criteria

The IPD and study protocol will be shared in an open-access data repository without restrictions.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphasia, Acquired

Clinical Trials on VR-based script training

Subscribe